BIO International Convention 2025

The BIO International Convention is the world’s most important event for the biotechnology industry, and it will be held from June 16 to 19, 2025, at the Boston Convention & Exhibition Center. This event brings together hundreds of top companies and institutions, including research centers, universities, hospitals, foundations, patient associations, financial institutions, and government agencies, both from the United States and internationally. The convention is organized by the Biotechnology Innovation Organization (BIO).

The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.

In a time of remarkable discovery and progress, the biotechnology industry stands at the forefront of a revolution changing how we live, heal, and care. From pioneering treatments offering hope to millions, to sustainable agricultural innovations to feed a growing population, or environmental breakthroughs securing our future, biotech drives positive change faster than ever. This progress is not just a change but a promise for a brighter future. The world is ready.

Whether you work at a public pharmaceutical company, biotech startup, academia, non-profit organization, or government agency; or you work as a researcher, business development professional or investor, BIO is where you'll make valuable connections and build relationships. Our proprietary BIO Partnering™ match-making platform—exclusive to the Premier Access registration package—allows you to find potential partners, schedule and accept meetings.

Biocat, the Government of Catalonia, and the Barcelona City Council, with the collaboration of HIPRA BIOTECH SERVICES, will host the Catalonia Networking Reception, which will take place as part of the BIO International Convention in Boston on June 16 at 6:00 PM.

This networking event is designed for professionals interested in connecting with the life sciences and biotechnology ecosystem of Catalonia and the United States. It is a unique opportunity to make new connections, explore collaborations, and open doors to future business opportunities.

The event will feature the active participation of members of the Catalan scientific community based in the Massachusetts area, who will foster interaction among attendees.

Registration open until June 1.

17/06/2025

12:15 PM- 1:30 PM

Navigating Barriers on the Journey from Molecule to Marketplace: Strategies for Global Commercialization Success

205ABC (Location)

Biopharma companies encounter crucial commercial barriers as they navigate their assets from molecule to marketplace. In a contemporary landscape where product types and therapies are diversifying, biopharma companies are searching for commercial partnerships that understand and address their unique needs rather than a one-size-fits-all model. During this session, Cencora experts will address the interdependent challenges biopharma companies face and provide strategies that orchestrate efforts across the industry to maximize the use of capital and drive commercial success.

Speakers:

• Sandra Anderson, Senior Vice President. Cencora
• Tom Doyle, Head US Commercial Solutions. Cencora
• Alexander Natz, Secretary General. EUCOPE
• Glenn Pauly, Former Chief Commercial Officer. Former Alzheon
• Kelly Price, Managing Director of US Rare Disease. Esteve

19/06/2025

9:00 AM-10:00 AM

An Eye on I&I: Innovations Fueling Growth

206AB (Location)

The global immunology market is projected to nearly double by 2032, expanding from $250 billion in 2023. Immunology and Inflammation (I&I) has now emerged as a top investment priority in biopharma, surpassing oncology in growth. This surge is fueled by groundbreaking innovations from both biotech and pharma. In this panel, leaders from four pioneering biotech and pharma companies, along with a leading venture capitalist, will explore the key scientific advancements, emerging platforms, and breakthrough technologies driving I&I growth. They will also discuss which innovations are attracting major investments and strategic industry partnerships, shaping the future of this rapidly evolving field.

Moderator:

• Allison deAngelis, Biotech Startups and Venture Capital ReporterBiotech Startups. STAT News

Speakers:

• Daniel Baker, Chief Development Officer. Cue Biopharma
• Kari Brown, Chief Medical Officer. Revolo Biotherapeutics
• Judy Chou, President and CEO. AltruBio
• Frank Nestle, Partner and CEO of 3DC. Deerfield Management
• Jose Terencio, Senior Vice President. Grifols